<p>Amid a rise in coronavirus cases and fears of a possible fourth wave in the country, in a massive boost to the vaccination drive, the Drugs Controller General of India (DCGI) on Tuesday (April 26) granted regulatory approvals to three coronavirus (COVID-19) vaccines, the country's health ministry confirmed.&nbsp;</p>

<p>Approval has been given to emergency use of Biological E's Covid vaccine Corbevax for children aged five to 12 and Bharat Biotech's Covaxin for six to 12-year olds.&nbsp;</p>

<p>The Corbevax is currently being administered to children in the age group of 12-14. Vaccinations against COVID-19 among minors in India were started from January 3 onwards with those in the 15-18 age group for Bharat Biotech's Covaxin.&nbsp;</p>

<p><strong>IN PICS |&nbsp;<a href="https://www.wionews.com/photos/mysterious-liver-disease-impact-kids-worldwide-here-are-leading-theories-is-there-any-link-to-covid-473832">Mysterious liver disease impact kids worldwide: Here are leading theories. Is there any link to Covid?</a></strong></p>

<p>DCGI has also granted emergency use authorisation to Cadila for its ZyCoV-D for an additional dose of 3mg with a two-jab inoculation schedule 28 days apart for those aged above 12 years. ZyCoV-D is, currently, approved for a 2mg three-dose vaccination schedule.&nbsp;</p>

<p>The approval by the Drugs Controller General of India (DCGI) comes following recommendations by the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO).</p>

<p><strong>WATCH |&nbsp;Gravitas: Inside China's Wuhan Virus Nightmare</strong></p>

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/gravitas-inside-chinas-wuhan-virus-nightmare-473843/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

<p>The drive later expanded on March 16 to include children aged above 12 for Corbevax. Overall India is currently administering two COVID-19 vaccines for children above 12.&nbsp;</p>

<p>Meanwhile, the country's Union Health Minister Mansukh Mandaviya tweeted, "India's fight against COVID becomes stronger @CDSCO_INDIA_INF gives nod to 'Covaxin' for 6-12 age group and 'Corbevax' for 5-12 age group for 'Restricted Use in Emergency Situations'"&nbsp;</p>

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<blockquote class="twitter-tweet">
<p dir="ltr" lang="hi">भारत की कोविड से लड़ाई अब और अधिक मज़बूत <a href="https://twitter.com/CDSCO_INDIA_INF?ref_src=twsrc%5Etfw">@CDSCO_INDIA_INF</a> ने<br />
<br />
&gt;6 से &lt;12 आयुवर्ग के लिए 'Covaxin'<br />
<br />
&gt;5 से &lt;12 आयुवर्ग के लिए 'Corbevax'<br />
<br />
12 से ऊपर के आयुवर्ग के लिए 'ZyCoV-D' की 2 डोज को<br />
<br />
'Restricted Use in Emergency Situations' की मंज़ूरी दी है।</p>
— Dr Mansukh Mandaviya (@mansukhmandviya) <a href="https://twitter.com/mansukhmandviya/status/1518863947386224641?ref_src=twsrc%5Etfw">April 26, 2022</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

<p><strong>WATCH WION LIVE HERE</strong></p>

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false"><iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe></div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

<p>&nbsp;</p>


Amid a rise in coronavirus cases and fears of a possible fourth wave in the country, in a massive boost to the vaccination drive, the Drugs Controller General of India (DCGI) on Tuesday (April 26) granted regulatory approvals to three coronavirus (COVID-19) vaccines, the country's health ministry confirmed.

Amid a rise in coronavirus cases and fears of a possible fourth wave in the country, in a massive boost to the vaccination drive, the Drugs Controller General of India (DCGI) on Tuesday (April 26) granted regulatory approvals to three coronavirus (COVID-19) vaccines, the country's health ministry confirmed. Approval has been given to emergency use of Biological E's Covid vaccine Corbevax for children aged five to 12 and Bharat Biotech's Covaxin for six to 12-year olds. The Corbevax is currently being administered to children in the age group of 12-14. Vaccinations against COVID-19 among minors in India were started from January 3 onwards with those in the 15-18 age group for Bharat Biotech's Covaxin. IN PICS | Mysterious liver disease impact kids worldwide: Here are leading theories. Is there any link to Covid? DCGI has also granted emergency use authorisation to Cadila for its ZyCoV-D for an additional dose of 3mg with a two-jab inoculation schedule 28 days apart for those aged above 12 years. ZyCoV-D is, currently, approved for a 2mg three-dose vaccination schedule. The approval by the Drugs Controller General of India (DCGI) comes following recommendations by the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO). WATCH | Gravitas: Inside China's Wuhan Virus Nightmare × The drive later expanded on March 16 to include children aged above 12 for Corbevax. Overall India is currently administering two COVID-19 vaccines for children above 12. Meanwhile, the country's Union Health Minister Mansukh Mandaviya tweeted, "India's fight against COVID becomes stronger @CDSCO_INDIA_INF gives nod to 'Covaxin' for 6-12 age group and 'Corbevax' for 5-12 age group for 'Restricted Use in Emergency Situations'" भारत की कोविड से लड़ाई अब और अधिक मज़बूत @CDSCO_INDIA_INF ने >6 से <12 आयुवर्ग के लिए 'Covaxin' >5 से <12 आयुवर्ग के लिए 'Corbevax' 12 से ऊपर के आयुवर्ग के लिए 'ZyCoV-D' की 2 डोज को 'Restricted Use in Emergency Situations' की मंज़ूरी दी है। — Dr Mansukh Mandaviya (@mansukhmandviya) April 26, 2022 × WATCH WION LIVE HERE ×

India gives emergency use authorisation to Covaxin for 6-12 age group

coronavirus-in-kids

Coronavirus In Kids, News on Coronavirus In Kids, stories on Coronavirus In Kids, articles on Coronavirus In Kids, Coronavirus In Kids stories at Wion, Coronavirus In Kids news, Coronavirus In Kids latest news

coronavirus in-kids

India gives emergency use authorisation to Covaxin for 6-12 age group